Lv1
10 积分 2021-08-13 加入
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
9小时前
待确认
Innate players in Th2 and non-Th2 asthma - emerging roles for the epithelial cell, mast cell and monocyte/macrophage network
1个月前
已完结
Role of Th1 and Th2 in autoimmunity
2个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
3个月前
已完结
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
3个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
7个月前
已完结
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
7个月前
已完结
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity
8个月前
已完结
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
8个月前
已关闭
NASH drug treatment development: challenges and lessons
11个月前
已完结
皖公网安备34019202002308
